Você procurou por: mediantiden (Dinamarquês - Inglês)

mediantiden til opståen var 10,0 uger.
median time to onset was 10.0 weeks.

mediantiden indtil operation var 261 dage.
the median time to surgery was 261 days.

mediantiden til start var 6,7 uger.
the median time to onset was 6.7 weeks.

mediantiden indtil debut var 7,5 dage.
the median time to onset was 7.5 days.

mediantiden til heling af såret var 14 dage.
median time to wound healing was 14 days.

mediantiden til grad 2 perifer neuropati var 18,4 uger.
the median time to grade 2 peripheral neuropathy was 18.4 weeks.

mediantiden indtil grad 3 eller 4 aminotransferasestigninger var 43 dage.
median time to onset of increased grade 3 or 4 transaminases was 43 days.

mediantiden indtil indtræden af en neurologisk hændelse var 9 dage.
the median time to onset of neurologic event was 9 days.

forlængelse af mediantiden indtil forværring (måneder) a,b
delay of median time to deterioration (months) a,b

mediantiden til trombocyttallet igen var over 50.000/mm3 var 14 dage.
the median time to recovery of platelet counts above 50,000/mm3 was 14 days.

mediantiden til respons var 1 (0,5 til 3,2) måned.
the median time to response was 1 (range: 0.5 to 3.2) month.

mediantiden til indtræden var 10,5 uger (2,1-27,0).
median time to onset was 10.5 weeks (range: 2.1-27.0).

mediantiden indtil progression var 186 dage (docetaxel+ capecitabin) vs.
the median time to progression was 186 days (docetaxel + capecitabine) vs.

14, 7 -31, 1%) , mediantiden for progression var 4, 1 måneder
14.7 -31.1%) , median time to progression was 4.1 months (ci:

i kliniske forsøg var mediantiden indtil respons 7,6-11,6 uger.
the median time to response in clinical trials was 7.6-11.6 weeks.

i kliniske forsøg var mediantiden tid indtil respons 7,6-11,6 uger.
the median time to response in clinical trials was 7.6-11.6 weeks.

mediantiden til grad 2 perifer neuropati var 12,6 uger (efter 4 cyklusser).
the median time to grade 2 peripheral neuropathy was 12.6 weeks (post 4 cycles).

14, 7 - 31, 1%), mediantiden for progression var 4, 1 måneder (ci:
14.7 - 31.1%), median time to progression was 4.1 months (ci:

mediantiden indtil respons var 3,1 måneder (95% ci 2,89; 3,65).
the median time to response was 3.1 months (95% ci 2.89, 3.65).

mediantid til indtræden var 0,5 måneder (0,0-9,7).
median time to onset was 0.5 months (range: 0.0-9.7).